Literature DB >> 8595268

Human papillomavirus infection.

J F Hines, S J Ghim, A B Jenson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8595268      PMCID： PMC2350365          DOI： 10.1136/bmj.312.7030.522

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study.

Authors:  M Lehtinen; J Dillner; P Knekt; T Luostarinen; A Aromaa; R Kirnbauer; P Koskela; J Paavonen; R Peto; J T Schiller; M Hakama
Journal:  BMJ       Date:  1996-03-02

2.  Loss of MHC class-I expression in cervical carcinomas.

Authors:  M E Connor; P L Stern
Journal:  Int J Cancer       Date:  1990-12-15       Impact factor: 7.396

3.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Authors:  R Kirnbauer; F Booy; N Cheng; D R Lowy; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

4.  HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions.

Authors:  S J Ghim; A B Jenson; R Schlegel
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

5.  Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells.

Authors:  M C Feltkamp; H L Smits; M P Vierboom; R P Minnaar; B M de Jongh; J W Drijfhout; J ter Schegget; C J Melief; W M Kast
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

6.  The expressed L1 proteins of HPV-1, HPV-6, and HPV-11 display type-specific epitopes with native conformation and reactivity with neutralizing and nonneutralizing antibodies.

Authors:  J F Hines; S J Ghim; N D Christensen; J W Kreider; W A Barnes; R Schlegel; A B Jenson
Journal:  Pathobiology       Date:  1994       Impact factor: 4.342

7.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

8.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.

Authors:  A T Lorincz; R Reid; A B Jenson; M D Greenberg; W Lancaster; R J Kurman
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

9.  Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination.

Authors:  J F Hines; S J Ghim; N D Christensen; J W Kreider; W A Barnes; R Schlegel; A B Jenson
Journal:  Gynecol Oncol       Date:  1994-10       Impact factor: 5.482
  9 in total
  2 in total

1.  Non-sexual transmission of human papillomavirus.

Authors:  P Mansour; M Abbott; M Iskander; S Dundas
Journal:  BMJ       Date:  1996-06-15

Review 2.  Human papillomavirus and bladder cancer.

Authors:  N R Boucher; J B Anderson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.